Master best practices for first-in-human study Costa Rica to enhance speed and efficiency in trials.
Introduction First-in-human (FIH) studies in Costa Rica offer a landscape rich with potential yet fraught with challenges for MedTech and Biopharma companies. With a regulatory framework shaped by Law 9234 and the oversight of the Ministry of Health, understanding compliance requirements is critical for successful study execution. So, how can you tap into local expertise and regulatory strategies to make your clinical trials more efficient and boost patient recruitment? This article explores best practices that not only tackle these challenges but also reveal the strategic advantages of conducting FIH studies in this vibrant Latin American market. Understand the Regulatory Landscape for FIH Studies in Costa Rica Navigating the compliance landscape for first-in-human study Costa Rica is fraught with challenges that demand careful attention. Conducting these studies requires a comprehensive understanding of the compliance framework established by the Ministry of Health (Ministerio de Sa…